BioWorld MedTech

Feb. 20, 2013

SEMDA 2013: Leahey: med-tech firms' voices still matter despite difficulties

ATLANTA — Some would say that in recent years the landscape for med-tech has been littered with difficulties and challenges often resulting in many devicemakers feeling as if their voice has been diminished. Read More

NewCo on the Go: ForeCYTE test like Pap smear for breast cancer

Report from Europe: Dune Medical in compliance for next-gen MarginProbe

Washington roundup: Neiman Institute offers rubric for evaluating repeat imaging

Financings roundup: PolyActiva raises more than $9M in Series B funding round

Agreements/contracts: Laser Spine partners with Marodyne for LivMD device

Deals roundup: Liaison sees opportunities in HIT via Ignis acquisition

HIT roundup: EMH Healthcare goes live on Capsule's MVP

Med-Tech Notes

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 20, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...